Oral and Dental Tolerance and Efficacy on Dentinal Hypersensitivity of a Dental Gel, on Adults
1 other identifier
interventional
55
1 country
1
Brief Summary
The aim of this clinical trial is to evaluate the tolerance and efficacy of a dental gel in patients with dentinal hypersensitivity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2015
CompletedFirst Posted
Study publicly available on registry
June 9, 2015
CompletedStudy Start
First participant enrolled
September 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedJune 9, 2015
June 1, 2015
6 months
June 1, 2015
June 4, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Global tolerance according to a 5-point grading scale taking into account physical signs observed and graded by the dentist and functionnal signs observed and graded by the patient
The global tolerance of the product is assessed by the dentist after 28 days of use, rated on a 5-point grading scale(good tolerance, very good tolerance, good tolerance, moderate tolerance) . The results of the global tolerance will take into account the physical signs observed by the dentist and the functional signs observed by the patients during the study
after 28 days
Secondary Outcomes (5)
Cold air stimulus score on the schiff cold air index as a mesure of immediate efficacy
5 and 60 minutes after application at day 1
Cold air stimulus score on the schiff cold air index as a mesure of short term efficacy
efficacy at day 4 and day 6
Cold air stimulus score on the schiff cold air index as a mesure of efficacy
between baseline and day 28
Tolerance with the record of functionnal signs reported by the dentist and physical signs reported by the patient.
during 28 days
Acceptability of the product assessed with a questionnaire
during 28 days
Other Outcomes (1)
Safety of the product with the record of adverse event during the study
during 28 days
Study Arms (1)
V063B-DP3003
OTHERall patients will received the study product (V063B-DP3003)
Interventions
The medical device V063B-DP3003 has been developed to relieve and decrease dentinal hypersensitivity in patients by creating a film around the sensitive tooth in order to prevent pain. Application modalities: apply a pea size amount of product (around 0.5g) onto each of the sensitive teeth, 3 times a day, by gentle massage with clean finger after each brushing of teeth. Do not rinse
Eligibility Criteria
You may qualify if:
- Male or female
- Aged between18 and 70 years included
- Having signed his/her written informed consent,
- If it is a woman of childbearing potential :
- Subject who can be reached in case of emergency,
- Subject willing to be compliant to the protocol,
- Subject able to fill out the daily log and the questionnaire.
- Subject with at least 20 natural teeth (especially on the studied teeth),
- Subject with an healthy gum status according to the investigator,
- Subject with a mild to moderate dentinal hypersensitivity on at least 2 hypersensitive non adjacent teeth: with a Schiff cold air index from 1 to 2
- Subjects who show a response typical of sensitivity to the cold air blast at visit 1.
You may not qualify if:
- Subject participating to any other biomedical research projects,
- For women : Pregnant or breastfeeding,
- Has forfeited his/her freedom by administrative or legal award or is under guardianship,
- Subject who, in the judgement of the investigator, is not likely to be compliant during the study,
- Subject unable to understand the information given (for linguistic or psychiatric reasons) and to give his/her consent in writing,
- Subject having dental braces
- Subject having immune system disorder,
- Subject having asthma,
- Subject having a disease liable to interfere with study data according to the investigator,
- Subject with teeth showing evidence of facets of attrition, premature contact, cracked enamel on the tooth to be studied and adjacent teeth,
- Subject with teeth showing evidence of irreversible pulpitis and active periodontal disease,
- Subject having caries on the tooth to be studied and adjacent teeth
- Subject having restauration of any type in the tooth to be studied,
- Subject having occlusal overload or occlusal adjustment recently made in the tooth to be studied,
- Subject with crowns , bridges in the area of sensitivity,
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Intertek Life Sciences
Cheshire, CH66 7NZ, United Kingdom
Study Officials
- STUDY CHAIR
GARNER Kelly
Intertek Life Sciences
- PRINCIPAL INVESTIGATOR
MACLURE Robert, MD
Intertek Life Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 1, 2015
First Posted
June 9, 2015
Study Start
September 1, 2015
Primary Completion
March 1, 2016
Study Completion
June 1, 2016
Last Updated
June 9, 2015
Record last verified: 2015-06